Further characterisation of an experimental model of tendinopathy in the horse.
Authors: Cadby J A, David F, van de Lest C, Bosch G, van Weeren P R, Snedeker J G, van Schie H T M
Journal: Equine veterinary journal
Summary
# Editorial Summary Superficial digital flexor tendon injuries carry notoriously poor prognoses in horses, with reinjury rates remaining stubbornly high—a problem that mirrors human tendinopathy. To better understand the degenerative processes underlying these injuries, Cadby and colleagues surgically created controlled lesions in the SDFT of six horses and characterised the tissue response at six weeks using clinical examination, biochemistry, histology, and immunohistochemistry. The injured tendons demonstrated hallmark features of clinical tendinopathy: disrupted collagen architecture, elevated glycosaminoglycan content, tenocyte morphological changes, increased matrix metalloproteinase activity, and evidence of neovascularisation, alongside notably sparse inflammatory infiltration. This reproducible model accurately captures the degenerative cascade seen in naturally occurring tendon injuries, making it valuable for both equine-specific research and comparative studies with human tendon pathology. For practitioners, the findings reinforce that post-injury tendon remodelling involves complex biochemical and structural changes extending well beyond initial inflammation, underscoring the importance of prolonged rehabilitation protocols and the potential role of targeted interventions to modulate MMP activity and collagen remodelling during recovery.
Read the full abstract on PubMed
Practical Takeaways
- •This validated model provides a research platform to test new therapeutic interventions for tendon injury, potentially accelerating development of treatments to improve outcomes and reduce reinjury rates in horses.
- •The model's replication of chronic tendinopathy characteristics (not acute inflammation) indicates that effective treatments likely need to target matrix degradation and remodeling rather than inflammation control alone.
- •Understanding that equine tendon injuries share fundamental pathological mechanisms with human tendinopathy suggests that evidence-based treatments developed in horses may be directly translatable to human athletes.
Key Findings
- •Experimental SDFT lesions in horses reproduced key pathological features of clinical tendinopathy including collagen fiber disruption, increased glycosaminoglycan content, and neovascularisation at 6 weeks post-surgery.
- •Lesioned tendons showed plump tenocyte nuclei and increased matrix metalloproteinase (MMP) activity consistent with degenerative changes seen in naturally occurring equine and human tendon disorders.
- •Scarcity of inflammatory cells at 6 weeks suggests the model reflects the chronic rather than acute phase of tendinopathy.
- •This experimental model demonstrates sufficient similarity to clinical tendinopathy to serve as a research tool applicable to both equine and human medicine.